saascode
analytics, bi & data·run 266 · Jul 2026

Amlaforge

A white-label workbench for financial-crime consultancies that maps approved regulatory interpretations to controls and customer-data requirements, records client gaps, and tracks reviewed remediation evidence without deciding compliance or customer risk.

Genesis score5.92/10
Make Amlaforge real.0/500
500 more votes and Amlaforge is authorized for build.
0%500 to authorize
Backing is the vote. When an idea crosses 500, we pull it into the build pipeline and ship it for real — the votes decide what gets built next, not an editor.
The opportunity
3Confirmed direct-to-institution readiness providers
0Confirmed consultancy-first workbenches found
0Verified required client-data interfaces
The case

The research confirms the European anti-money-laundering regulation's main application date in July 2027 and multiple readiness offerings sold directly to financial institutions. It found no reviewed product designed specifically as a white-label engagement workbench for the consultancy serving those institutions. The cited readiness survey indicates substantial preparation work, but its sample and methodology require review before public use.

Amlaforge should separate official source, qualified interpretation, applicability decision, control requirement, data requirement, client source inventory, data-quality test, gap candidate, consultant finding, client acceptance, remediation action, implementation evidence, retest and accountable compliance conclusion. A missing field is not automatically a legal breach, customer risk or suspicious activity.

The product cannot provide legal advice, determine whether an institution or customer complies, assign customer risk, perform sanctions or transaction-monitoring decisions, file reports or certify readiness. White-label delivery must preserve source provenance, consultancy responsibility and client approval rather than conceal who made each judgment.

Who pays — and why

AML and financial-crime compliance consultancies running repeatable readiness engagements for European financial-services clients.

What it unlocks
An authority register with official source, provision, version, effective date, jurisdiction, entity and product scope, qualified interpreter, interpretation, uncertainty, review and approval
A control-and-data matrix linking each approved interpretation to control objective, required data concept, allowed evidence, owner, applicability, status, test method, exception and review cadence
A client-book assessment separating source inventory, field mapping, provenance, lawful purpose, quality test, missing or inconsistent data, alternative explanation, gap candidate, consultant finding and client acceptance
A remediation tracker with priority rationale, action owner, dependency, due date, implementation evidence, independent retest, residual issue, client decision, qualified conclusion, export and audit history
How Genesis scored it
5.92across seven criteria
tension 7temporal 7blindspot 5buyer 5leverage 5convergence 5why-not 7
7
Productive tension

Reusable control structure must coexist with institution-specific applicability, data rights and professional judgment.

7
Temporal window

The main application date creates a bounded preparation window.

5
Convergence

Several related compliance ideas and one inbound connection support the direction.

Why it scored well

A confirmed regulatory date, visible readiness gap and unoccupied consultancy-buyer angle make the workflow timely.

What's holding it back

Buyer role and budget, official interpretation, client data access, lawful purpose, consultancy adoption and repeatable economics need validation.

Signals detected3 sources crossed
SignalGenesis research

SignalGenesis research

SignalGenesis research

Direction briefamlaforge.md
amlaforge.md
Want this pointed at your vertical?Point Genesis at your own market and constraints — it invents adjacent, fork-ready ideas, private to you before they hit the public feed.

Discussion

?

No comments yet — be the first to weigh in.